‹ All Posts
Chahat Aggrawal

21st Jun · SEBI-Registered Analyst

MedPlus Subsidiary Receives Drug License Suspension Order

⚖️ $MEDPLUS disclosed that its subsidiary Optival Health Solutions Private Limited has received a 10-day drug license suspension order from the FDA Maharashtra. The order cites alleged violations under the Drugs and Cosmetics Act, 1940, and pertains to the subsidiary's pharmacy operations.

#StockInNews#FundamentalViews
818 likes·73 comments